1)Cel

luni
tofheal
th
● Di
agr
am ofcel
lcy
cle
● Cel
lcy
cleandnamesoft
hreegr
owt
hfact
ors(
prof
f5mk)

2)Cel
linj
ury
,cel
ldeat
handadapt
ati
ons
● (
4x)
Dif
fer
encebet
weenapopt
osi
sandnecr
osi
s(sem 4mkand
pr
ofs5mk)
● Di
ff
erencebet
weenmet
ast
ati
canddy
str
ophi
c
cal
ci
fi
cat
ion(
sem 4mk)
● I
ntr
insi
cpat
hwayofapopt
osi
s(sem 4mk)
● (
2x)
Diagr
am ofext
ri
nsi
cpat
hwayofapopt
osi
s(sem 3mk)
● Apopt
osi
s(12mk)
:def
inat
ion,
mor
phol
ogi
cal
and
bi
ochemi
cal
changes
● Coagul
ati
venecr
osi
s(pr
off4mk)
● Tel
omer
e(pr
off4mk)
● Endogenouspi
gment
s(pr
off5mk)
● Dy
str
ophi
ccal
cif
icat
ionwi
thexampl
es(
prof
f5mk)
● Met
apl
asi
awi
thaf
ewexampl
es(
prof
f5mk)

3)I
nfl
ammat
ion
● (
5x)
Granul
omadi
agr
am(
sem 4mks)
● Gr
anul
omadi
agr
am(
sem 2mk)
● Gr
anul
omasn(
prof
f4mk)
● (
2x)
Dif
fbwheal
i
ngbypr
imar
yandsecondar
yint
ent
ion(
sem 4mk;
pr
ofs4mk)
● (
2x)
Fact
orsaf
fect
ionwoundheal
i
ng(
prof
f4mk)
● Cel
l
ularev
ent
sinacut
einf
lammat
ion(
prof
f4mk)
● Out
comesofacut
einf
lammat
ion(
prof
f4mk)
 ● Pr
ost
agl
andi
ns(
prof
f5mk)

4)Hemody
nami
cdi
sor
der
s
● Di
ffbet
weent
hrombosi
sandembol
i
sm(
sem 4mk)
● Di
ffbwr
edandwhi
tei
nfar
ct(
sem 4mk)
● Shock(
prof
f12mk)
:def
ine,
types,
eti
opat
hogeni
sisandmor
phol
ogi
cal
changesofsept
icshock
● Di
agr
am ofv
irchow’
str
iad(
sem 3mk)
● Di
ffbwt
ransduat
eandexudat
e(5mk)
● (
2x)
Edema(
prof
f5mkandsem 7mk)
● Di
agr
am ofcoagul
ati
oncascade(
sem 4mk)
● (
2x)
Fat
eoft
hrombus(
sem 5mkandpr
ofs4mk)
● Fatembol
i
sm(
prof
f5mk)
:di
agnosi
s,pat
hogenesi
s,t
woabnor
mal
i
tiesi
n
hemat
ologi
cal
findi
ngs
● Embol
i
sm(
prof
f4mk)
● Di
agr
am ofcoagul
ati
oncascade(
sem 4mk)

5)Genet
icdi
seases
● (
4x)
Down’
ssy
ndr
ome(
sem 4mk;
prof
f4mk)

● Down’
ssy
ndr
ome(
prof
f5mk):
reasonst
osupppor
tsdi
agnosi
s,pat
hogenesi
s

● Pat
ausy
ndr
ome(
prof
f4mk)

6)Di
seasesofi
mmunesy
stem
● (
2x)
Stai
ningpr
oper
ti
esofamy
loi
dosi
s(sem 4mk)
● Amy
loi
dosi
s(sem 7mk)
:cl
assi
fi
cat
ion,
secondar
yamy
loi
dosi
s,
speci
alst
ains
● Amy
loi
dosi
scl
assi
fi
cat
ionandcompl
i
cat
ions(
sem 10mk)
● Amy
loi
dosi
s(pr
off5mk)
:cl
assi
fi
cat
ion,
pat
hogenesi
s
● (
2x)
AIDS:
CDCcl
assi
fi
cat
ion,
4oppor
tuni
sti
cinf
ect
ions(
Sem3mk
 7mk)
● (
2x)
AIDSoppor
tuni
sti
cinf
ect
ions(
prof
f4mk)
● SLE(
sem 7mk)
:di
agnosi
s
● Ty
pe1hy
per
sensi
ti
vi
ty(
prof
f4mk)
● Ty
pe4hy
per
sensi
ti
vi
ty(
prof
f4mk)
● Gr
aftv
shostdi
sease(
sem 6mk)

7)Neopl
asi
a
● Neopl
asi
a(sem 8mk)
:def
inat
ion,
over
viewofcar
cinogenesi
s
● Neopl
asi
a(pr
off11mk)
:def
inat
ion,
dif
fer
encesbet
weenbeni
gnand
mal
i
gnant
,par
aneopl
ast
icsy
ndr
omes
● Di
ff
erencebet
weenbeni
gnandmal
i
gnantt
umour
(sem 4mk)
● (
2x)
P53asmol
ecul
arpol
i
ceman(
sem 4mk;
prof
f5mk)
● (
2x)
Endocr
inopat
hiesi
npar
aneopl
ast
icsy
ndr
ome(
sem 4mk;
pr
off5mk)
● (
2x)
Par
aneopl
ast
icsy
ndr
omes(pr
off5mkand9mk)
● (
2x)
Vir
aloncogenesi
s(pr
off6mkandsem 4mk)
● Oncogeni
cvi
ruses(
sem 4mk)
● Oncogeni
cDNAv
iruseswi
thexampl
es(
prof
f5mk)
● (
3x)
Gradi
ngandst
agi
ngoft
umour
s(pr
off5mk
andsem 6mk)
● Tumormar
ker
s(pr
off4mk)
● (
2x)
HPVi
ncer
vical
cancer
(pr
off4mk)
● (
3x)
Phi
l
edel
phi
achr
omosome(
prof
f4mk,
sem 4mk)
● Di
ffbwmet
apl
asi
aanddy
spl
asi
a(pr
off5mk)
● Knudsonhy
pot
hesi
s(pr
off4mk)

8)I
nfect
iousdi
seases
● Labor
ator
ydi
agnosi
sofsy
phi
l
is(
sem 4mk)
● Labdi
agnosi
sofpul
monar
yTB(
prof
f5mk)
● (
2x)
Dif
fbwl
epr
omat
ousandt
uber
cul
oidl
epr
osy
(pr
off4mkand
5mk)
 ● Tubur
cul
osi
s(8mk)
:pat
hogenesi
s,mor
phol
ogy
,compl
i
cat
ions
ofpr
imar
ytb
● Tuber
cul
osi
s(pr
off12mk)
:di
agnosi
s(2mk)
,tr
ansmi
ssi
on(
1mk)
,
pat
hogenesi
sindi
agr
am(
3mk)
,gr
ossandmi
croscopi
c
change(
3mk)
,twohemat
ologi
cal
test
swhi
chwi
l
lbe
abnor
mal
(2mk)
,twoot
hert
est
s(1mk)
● Fat
eofpr
imar
yTB(
sem 4mk)
● Labdi
agnosi
sofHSV2(
sem 6mk)
● Lepr
osy
(sem 7mk)
:di
agnosi
s,cl
assi
fi
cat
ion

11)Bl
oodv
essel
s
● (
2x)
Ather
omat
ouspl
aquedi
agr
am(
sem 4mk)
● At
her
omadi
agr
am(
sem 2mk)
● At
her
oscl
erosi
s(pr
off7mk)
:pat
hogenesi
s,mor
phol
ogy
,compl
i
cat
ions
● At
her
oscl
erosi
s:compl
i
cat
ions(
Prof
f5mk)
● Vascul
archangesi
nat
her
oscl
erosi
s(pr
off4mk)

12)Thehear
t
● (
3x)
Evol
uti
onofmi
croscopi
cchangesi
nMIdi
agr
am(
sem 4mk)
● Di
agr
am of4t
ypesofv
eget
ati
veendocar
dit
is(
sem 3mk)
● I
HDsy
ndr
omesenumer
ateandt
abul
atet
empor
alev
olut
ionofmi
croscopi
c
changesi
nacut
eMI
● MI
(pr
off11mk)
:pat
hogenesi
s,t
empor
alev
olut
ionofmor
phol
ogi
cchanges,
compl
i
cat
ions
● 4maj
ort
ypesofv
eget
ati
veendocar
dit
is(
prof
f4mk)
● Di
ffbwv
eget
ati
onofRHDandi
nfect
iveendocar
dit
is(
sem 4mk)
● MI
(sem 7mk)
:pr
edi
sposi
ngf
act
ors,
chr
onol
ogyofmor
phol
ogi
cal
changes

13)WBCdi
sor
der
s

 Peri
pher
albl
oodpi
ctur
eofacut
epr
omy
elocy
ticl
eukemi
a(sem 4mk)

 Di
agr
am ofper
ipher
albl
oodsmeari
nCML(
sem 4mk)
  Peri
pher
albl
oodf
indi
ngsi
nCLL(
sem 6mk)

 Cl
assi
fi
cat
ionofacut
emy
eloi
dleukemi
a(sem 5mk)

 WHOcl
assi
fi
cat
ionofHodgki
n’
sly
mphoma(
sem 4mk)

 Cl
assi
cal
hodgki
n’
sly
mphoma(
sem 5mk)

 (2x)RScel
l
sandt
hei
rvar
ient
s(sem 6mk,
prof
f4mk)

 RScel
l
(sem 4mk)

 Di
ff
erencebet
weenhodgki
n’
sandnon-
hodgki
n’
sly
mphoma(
prof
f4mk)

 Di
ff
erencebet
weenLeukemoi
dreact
ionsandl
eukemi
a(sem 4mk)

 BM fi
ndi
ngsi
nmul
ti
plemy
eloma(
prof
f5mk)

 Labdi
agnosi
sofmul
ti
plemy
eloma(
prof
f5mk)

14)RBCandbl
eedi
ngdi
sor
der
s
● (
5x)
Per
ipher
albl
oodpi
ctur
eofmegal
obl
asi
canaemi
adi
agr
am(
sem 4mk)
● Bombaybl
oodgr
oup(
sem 4mk)
● Di
agr
am ofper
ipher
alsmearf
indi
ngsi
nthal
assemi
amaj
or(
sem 2mk)
● Labdi
agnosi
sof2y
eol
dmal
echi
l
dwi
thhemar
thr
osi
sandl
argeecchy
mosi
s
andposi
ti
vef
ami
l
yhi
stor
y(sem 7mk)
● Bombaybl
oodgr
oup(
sem 4mk)
● Rhf
act
or(
prof
f4mk)
● (
3x)
Rhi
ncompat
ibi
l
ity
(sem 4mk)
:er
ythr
obl
ast
osi
sfeot
ali
s
● (
2x)
DIC(
sem 5mk)
● (
2x)
Eti
opat
hogeni
sisofDI
C(sem 6mk)
● (
2x)
Transf
usi
onr
eact
ions(
prof
f5mk,
sem 5mk)
● (
2x)
Transf
usi
ont
ransmi
tt
edi
nfect
ions(
prof
f5mk)
● Enumer
ate5TTIf
orwhi
chbl
oodi
sscr
eened(
sem 5mk)
● Sel
ect
ioncr
it
eri
aforbl
ooddonor
s(pr
off4mk)
 ● I
DA:
diagnosi
s(1mk)
,per
ipher
alsmearf
indi
ngs(
2mk)
,2bi
ochemi
cal
test
sto
cnf
m(1mk)
● Pat
hogenesi
sofI
DA(
prof
f5mk)
● I
DA(
prof
f5mk)
:di
agnosi
s,i
nvest
igat
ions,
pat
hogenesi
s
● I
DA(
prof
f6mk)
:causes,
hemat
ologi
cal
findi
ngs,
cli
nical
present
ati
on
● Megal
obl
ast
icanaemi
a(sem 7mk)
:di
agnosi
s,i
nvest
igat
ions
● Bonemar
rowf
indi
ngsi
nmegal
obl
ast
icanaemi
a(sem 4mk)
● Anemi
a(pr
off
):def
ine(
2mk)
,cl
assi
fyhemol
yti
canemi
a(2mk)
,labor
ator
y
di
agnosi
sofbet
athal
assemi
amaj
or(
5mk)
,di
agr
am per
ipher
alsmearf
indi
ngs
i
nsame(
3mk)
● Coomb’
stest
(pr
off4mk)
● Bet
athal
asemmi
a(pr
off5mk)
:di
agnosi
s,l
abi
nvest
igat
ions,
pat
hogenesi
s
● Labdi
agnosi
sinpancy
topeni
a(sem 7mk)
● Di
agr
am ofr
egul
ati
onofi
ronabsor
pti
on(
sem 4mk)
● I
diopat
hict
hrombocy
topeni
cpur
pur
a(pr
off5mk)

15)Thel
ung
● Ty
pesofemphy
sema(
sem 4mk)
● Pr
e-neopl
ast
icl
esi
onsf
orl
ungt
umour
s(sem 5mk)
● Di
agnost
icI
HCmar
ker
sin35y
rol
dlady
,asi
annonsmokerwi
thl
ung
cancer
(sem 5mk)
● 38y
rasi
anf
emal
ewhoi
snon-
smokerdev
elopedmassi
nlung.Di
agnosi
s,one
pr
ecur
sorl
esi
on,
2mut
ati
onsi
mpl
i
cat
ed(
prof
f5mk)
● I
HCmar
ker
sincar
cinomal
ung(
prof
f4mk)
● Lungcar
cinoma(
prof
f5mk)
:di
agnosi
s,pat
hogenesi
s,r
iskf
act
ors,
gross
mi
croscopi
candhi
stopat
hol
ogi
cal
types
● Cl
assi
fi
cat
ionofl
ungt
umour
s,I
HCmar
ker
sofl
ungcar
cinoma,
par
aneopl
ast
icsy
ndr
omesassoci
atedwi
thl
ungt
umour
s(sem 8mk)
● Panaci
naremphy
sema(
sem 5mk)
● Cl
assi
fi
cat
ionofpneumoni
a(sem 4mk)
● Di
agr
am ofsquamouscel
lcar
cinomaofl
ung(
sem 4mk)

16)Headandneck
 ● (
2x)
Eti
ologi
cri
skf
act
orsi
nor
alsquamouscel
lcar
cinoma(
sem 5mk,
6mk)
● (
2x)
33y
rol
dman,
H/Osmoki
ng,
ulceronl
atbor
deroft
ongue(
ir
regul
ar,
3cm
andi
ndur
atedbor
der
s),
lev
el4l
ymphnodes:
diagnosi
s(1mk)
,pr
e-neopl
ast
ic
condi
ti
onsassoci
ated(
3mk)
,tumourst
agi
ngandgr
adi
ng(
4mk)
,cl
i
nical
and
hi
stol
ogi
cpr
ogr
essi
onoft
hesel
esi
ons(
3mk)
● Cl
assi
fysal
i
var
ygl
andt
umour
s(pr
off4mk)
● Leukopl
aki
a(pr
off4mk)

17)Thegast
roi
ntest
inal
tract
● (
3x)
Diagr
am ofgast
ri
cul
cer
(sem 4mk)
● (
2x)
Diagr
am ofcompar
isonoft
uber
cul
arandt
yphoi
dul
ceri
nint
est
ine(
sem
4mk)
● Di
ffbwH.
pyl
ori
associ
atedandaut
oimmunegast
ri
ti
s
● (
4x)
Dif
fbwul
cer
ati
vecol
i
tisandcr
ohn’
sdi
sease(
sem 5mk,
4mk)
● Mi
croscopi
cfeat
uresofcr
ohn’
sdi
sease(
prof
f4mk)
● Cr
ohn’
sdi
sease(
sem 6mk)
● Li
nit
ispl
ast
ica(
sem 6mk)
● Bi
opsyf
indi
ngsofcoel
i
acdi
sease(
sem 6mk)
● (
2x)
Vir
ulencef
act
orsofH.
pyl
ori
(pr
off4mk)
● Cl
assi
fi
cat
ionofchr
oni
cgast
ri
ti
s,v
irul
encef
act
orsofH.
pyl
ori
(sem 6mk)

18)Li
verandgal
lbl
adder

 (
2x)
Sequenceofser
ologi
cal
mar
ker
sforHepBhepat
it
is(
sem 5mk,
prof
f4mk)

 Di
agr
am oft
empor
alchangesi
nser
ologi
cal
mar
ker
sinacut
eHepBi
nfect
ion
wi
thr
esol
uti
on(
sem 4mk)

 Di
agr
am ofser
ologi
cal
mar
ker
sinHepBpr
ogr
essi
vechr
oni
cinf
ect
ion(
sem
4mk)

 Di
agr
am ofhepat
it
isBv
iral
str
uct
ure(
sem 4mk)

 Et
iopat
hogenesi
sofv
iral
hepat
it
isandt
empor
alchangesi
nser
ologi
cmar
ker
s
i
nHepBi
nfect
ion(
sem 7mk)

 Rol
eofv
irusesi
nhepat
ocel
l
ularcar
cinoma(
sem 6mk)
  Al
cohol
i
cli
verdi
sease(
prof
f4mk)

 Ty
pesofgal
l
stones(
sem 5mk)

 Nor
mal
bil
i
rubi
nmet
abol
i
sm(
sem 4mk)

 Ur
inef
indi
ngsi
nobst
ruct
ivej
aundi
ce(
sem 5mk)

20)Theki
dney

 (2x)Di
agr
am oful
tr
ast
ruct
ureofgl
omer
ulus(
sem 4mk)

 Di
agr
am ofcl
earcel
lcar
cinomaki
dney
(sem 4mk)

 Di
agr
am ofschemat
icEM pi
ctur
eofgl
omer
ulus(
sem 4mk)

 Di
ff
erencebet
weenacut
enephr
it
icsy
ndr
omeandnephr
oti
csy
ndr
ome(
sem

4mk)

 Heredi
tor
ysy
ndr
omesassoci
atedwi
thr
enal
cel
lcar
cinoma(
sem 5mk)

 Cl
assi
fyr
enal
cel
ltumor
s.Ment
ionher
edi
tor
ysy
ndr
omesassoci
atedwi
th

r
enal
cel
lcar
cinoma.Wr
it
einbr
iefaboutr
enal
cel
lcar
cinoma(
sem 7mk)

 Cl
i
nical
mani
fest
ati
onsofnephr
oti
csy
ndr
ome(
prof
f4mk)

 Li
stf
eat
uresandennumer
atecausesofnephr
oti
csy
ndr
ome.

Et
iopat
hogenesi
sandmor
phol
ogyofmi
nimal
changedi
sease(
prof
f11mk)

 Defi
nenephr
oti
csy
ndr
ome.Et
iopat
hogenesi
sofandel
abor
ateon

membr
anopr
oli
fer
ati
vegl
omer
ulonephr
it
is(
prof
f12mk)

 Defi
nenephr
oti
csy
ndr
ome.Mor
phol
ogi
cfeat
uresi
nki
dneyi
ndi
abet
ic

nephr
opat
hy(
sem 7mk)

 Nephri
ti
csy
ndr
ome(
prof
fPr
off5mk)
:di
agnosi
s,l
abf
indi
ngsi
nur
ine

exami
nat
ion,
diagnost
iccr
it
eri
a
  (2x)Enumeratei
mmunemechani
smsofgl
omer
ulari
njur
yanddr
awdi
agr
am

ofl
ocal
i
sat
ionofi
mmunecompl
exesi
ngl
omer
ulus(
sem 7mk)

 (2x)Uri
nar
ycast
s(sem 4mk)

21)Thel
owerur
inar
ytr
actandmal
egeni
tal
syst
em

 Di
agr
am ofmi
croscopi
cpi
ctur
eofsemi
noma(
sem 4mk)

 Speci
alst
ainsandI
HCi
ncl
assi
cal
semi
noma(
prof
f4mk)

 Semi
noma(
prof
f4mk)

 Dysgermi
noma(
prof
f4mk)

 Beni
gnpr
ost
ati
chy
per
plasi
a(pr
off4mk)

 Enumerat
eri
skf
act
orsf
ordev
elopmentofcar
cinomaofpr
ost
ate(
sem 5mk)

 Bri
efout
li
nei
nvest
igat
ionsf
ormal
einf
ert
il
it
y(sem 4mk)

22)Thef
emal
egeni
talt
ract

 Cl
assi
fyov
ari
ant
umor
sindet
ail
.Pat
hogenesi
sofser
ousov
ari
ant
umor
s(sem

7mk)

 (2x)HPVi
ncer
vical
cancer
(pr
off4mk)

23)Thebr
east

 Pat
hol
ogi
cal
inv
est
igat
ionsofbr
eastCa(
sem 4mk)

 Br
eastCa(
sem 7mk)
:gr
adi
ngsy
stem,
otheri
nvest
igat
ions,
prognost
icf
act
ors

 Br
easetCa(
sem 7mk)
:di
agnosi
s,l
abor
ator
ytest
stoconf
ir
m,t
hree
est
abl
i
shedbi
omar
ker
sfort
hecondi
ti
onwi
tht
hei
rlocal
i
sat
ion

 Cl
assi
fi
cat
ionofbr
eastt
umor
sandpr
ognost
icf
acot
rs(
sem 7mk)
  Br
eastCa(
prof
f12mk)
:di
agnosi
s,pat
hogenesi
s,r
iskf
act
ors,
prognost
ic
f
act
ors

 Br
eastCa(
prof
f12mk)
:di
agnosi
sandr
easons,
classi
fi
cat
ion,
riskf
act
orsand
pat
hogenesi
s,gr
ossandmi
croscopi
cfeat
ures,
predi
cti
vef
act
orsi
ntr
eat
ment

 2cm f
ir
m mobi
l
elumpi
nbr
east
.2i
nvest
igat
ionswhi
chwi
l
ldef
ini
tel
ydi
agnose.
Dr
awdi
agr
am f
orsame(
prof
f5mk)

 Br
eastCa(
sem 4mk)
:pat
hol
ogi
cal
inv
est
igat
ionsf
oest
abl
i
shdi
agnosi
s

 Pr
ognost
icf
act
orsi
nbr
eastCa(
prof
f5mk)

24)Theendocr
inesy
stem
● DM(
sem 7mk)
:Hb1ac,
micr
ovascul
arcompl
i
cat
ions
● DM(
sem 7mk)
:WHOcr
it
eri
a,pat
hogenesi
soft
ype2
● Ur
inef
indi
ngsi
ndi
abt
eti
cket
oaci
dosi
s(pr
off4mk)
● Di
abet
icmacr
ovascul
ardi
sease(
prof
f4mkand5mk)
● Di
abet
icnephr
opat
hy(
prof
f4mk)
● Mi
crov
ascul
archangesi
nDM(
sem 5mk)
● Macr
ovascul
arcompl
i
cat
ionsofDM(
prof
f5mk)
● Nucl
earf
eat
uresi
npapi
l
lar
yCat
hyr
oid(
prof
f4mk)
● (
2x)
Micr
oscopi
cfeat
uresi
npapi
l
lar
yCat
hyr
oid(
sem 4mk,
prof
f4mk)
● Hi
stopat
hol
ogi
cal
feat
uresofpapi
l
lar
yCat
hyr
oid(
prof
f4mk)
● Hashi
mot
othy
roi
dit
is(
prof
f4mk)

25)Theski
n

 Basalcel
lcar
cinoma(
prof
f4mk)

26)Bone,
joi
ntsandsof
tti
ssuet
umor
s

 Osteocl
ast
oma(
sem 5mk,
prof
f4mk)

 Gi
antcel
ltumorofbonewi
thdi
agr
am(
sem 4mk)
28)Thecent
ralner
voussy
stem

 (2xMeni
ngi
oma(
sem 5mk,
prof
f4mk)
)

 Meni
ngi
ti
s(pr
off10mk)
:di
agnosi
s,commoncausat
iveor
gani
sms,
two

bi
ochemi
cal
test
stoconf
ir
m di
agnosi
s

 CSFfi
ndi
ngsi
ntuber
cul
armeni
ngi
ti
s(sem 4mk)

 (3x)CSFexami
nat
ioni
npy
ogeni
cmeni
ngi
ti
s(sem 4mk,
prof
f4mk)

Somewher
e

 Lei
omy
omav
slei
omy
osar
coma(
sem 5mk)

 (2x)Freeradi
cal
s(sem 4mk)

I
ndi
cat
ionsofbonemar
rowi
nvest
igat
ion(
sem 4mk)

 ESR(proff4mk)